These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9624543)

  • 21. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.
    Periti P; Novelli A; Schildwachter G; Schmidt-Gayk H; Ryo Y; Zuck P
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():63-9. PubMed ID: 2292532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two oral antibiotics, roxithromycin and amoxicillin plus clavulanic acid, in lower respiratory tract infections.
    Dautzenberg B; Scheimberg A; Brambilla C; Camus P; Godard P; Guerin JC; Lemarie E; Rezvani Y; Rosembaum M; Tuchais E
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):85S-89S. PubMed ID: 1617930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Cranfield R; Breisch S; Pettit R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
    Smith JW; Nichols RL
    Am J Med; 1993 Mar; 94(3A):150S-154S. PubMed ID: 8452172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
    Pelletier LL
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.
    Gooch WM; Blair E; Puopolo A; Paster RZ; Schwartz RH; Miller HC; Smyre HL; Yetman R; Giguere GG; Collins JJ
    Pediatr Infect Dis J; 1996 Feb; 15(2):157-64. PubMed ID: 8822290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults.
    Namyslowski G; Misiolek M; Czecior E; Malafiej E; Orecka B; Namyslowski P; Misiolek H
    J Chemother; 2002 Oct; 14(5):508-17. PubMed ID: 12462431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative clinical and microbiological study of amoxycillin-clavulanic acid and ciprofloxacin in acute purulent exacerbations of chronic bronchitis.
    Legnani D; Lombardo VM; Negretto GG; Beghi G; Caratozzolo O
    J Hosp Infect; 1992 Nov; 22 Suppl A():69-74. PubMed ID: 1362752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
    O'Doherty B; Daniel R
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
    Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
    Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
    Jackson J; Fernandes AW; Nelson W
    Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azithromycin for acute lower respiratory tract infections.
    Panpanich R; Lerttrakarnnon P; Laopaiboon M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A; Fisher CL; Busman T; Olson CA
    Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
    Martinot JB; Carr WD; Cullen S; Heredia Budo JL; Bauer K; MacLeod C; Sanguinetti CM; van Veldhuizen WC;
    Adv Ther; 2001; 18(1):1-11. PubMed ID: 11512528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S; Breton J; Wynne B
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
    Gehanno P; Berche P; Boucot I; Lambert-Zechovsky N; Bingen E; Gres JJ; Rollin C
    J Antimicrob Chemother; 1994 Jun; 33(6):1209-18. PubMed ID: 7928814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
    Subba Rao SD; Macias MP; Dillman CA; Ramos BD; Kierszenbaum JS; Soliman AE
    J Chemother; 1998 Dec; 10(6):460-8. PubMed ID: 9876054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
    Biebuyck XA
    J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
    Read RC; Kuss A; Berrisoul F; Kearsley N; Torres A; Kubin R
    Respir Med; 1999 Apr; 93(4):252-61. PubMed ID: 10464889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.
    Van Royen P; Betz W; Heyrman J; Taziaux P; Van den Haute M; Poelman M
    J Int Med Res; 1997; 25(1):33-40. PubMed ID: 9027671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.